臀位:CNGOF临床实践指南——外倒转术及其他转胎干预
本指南由法国国家妇产科医师学院(CNGOF)制定,检索1980—2019年MedLine与Cochrane Library文献并参考主要国外指南。ECV可降低臀位分娩率(LE2),可能降低剖宫产率(LE3),不增加严重母体(LE3)和围产期(LE3)并发症,故建议足月臀位产妇应被告知尝试ECV(专业共识)。37周前ECV较37周后提高头位分娩率(LE2)但轻度早产风险略增(LE2),建议自36周开始尝试(专业共识)。足月ECV使用胃肠外宫缩抑制药(β受体激动剂或阿托西班)提高成功率(LE2),推荐使用(grade B)。操作前后需胎心监护,不推荐常规Kleihauer试验,Rh阴性者需系统预防。针灸、艾灸和体位方法无效,不推荐(Grade B)。
要点
- 足月臀位产妇应被告知尝试ECV,可降低臀位分娩率(LE2)并可能降低剖宫产率(LE3),不增加严重母体(LE3)和围产期(LE3)并发症(专业共识)。
- ECV尝试应在可立即获得急诊剖宫产手术室的条件下进行(专业共识)。
- 足月ECV推荐使用胃肠外宫缩抑制药(β受体激动剂或阿托西班)以提高成功率(grade B),可提高头位分娩率(LE2)并降低剖宫产率(LE2)。
- ECV尝试建议自36周开始(专业共识);37周前ECV较37周后提高头位分娩率(LE2)但轻度早产风险略增(LE2)。
- ECV操作前及操作后30分钟内应行胎心监护(专业共识);不推荐常规Kleihauer试验(专业共识),Rh-1阴性者应系统预防(专业共识);针灸、艾灸和体位方法不推荐(Grade B)。
适用人群与场景
- 足月臀位产妇,应被告知尝试ECV(专业共识)。
- ECV尝试建议自36周开始(专业共识)。
处置流程与药物剂量
- 足月臀位产妇应被告知尝试ECV以降低臀位分娩率和剖宫产率(专业共识)。
- ECV尝试应在可立即获得急诊剖宫产手术室的条件下进行(专业共识)。
- 足月ECV推荐使用胃肠外宫缩抑制药(β受体激动剂或阿托西班)以提高成功率(grade B)。
- ECV操作前及操作后30分钟内应行胎心监护(专业共识);不推荐ECV后延迟胎心监护(专业共识)。
- 不推荐ECV后常规行Kleihauer试验(专业共识);Rh-1阴性妇女应系统进行Rh-1预防(专业共识)。
- 足月臀位不推荐针灸、艾灸和体位方法(Grade B)。
研究设计与关键结果
- ECV与臀位分娩率降低相关(LE2),可能降低剖宫产率(LE3),不增加严重母体并发症(LE3)和围产期并发症(LE3)。
- 37周前ECV较37周后ECV提高头位分娩率(LE2),但轻度早产风险略增(LE2)。
- ECV成功的主要相关因素为经产(LE3)和无母体肥胖(LE3)。
- 足月ECV使用胃肠外宫缩抑制药(β受体激动剂或阿托西班)与更高成功率(LE2)、更高分娩时头位率(LE2)和更低剖宫产率(LE2)相关。
- ECV尝试与一过性胎心异常增加相关(LE3)。
- ECV后Kleihauer试验显著阳性(>30mL)风险低(<0.1%)(LE3)。
- 足月臀位针灸、艾灸和体位方法不能有效降低臀位分娩率(LE2)。
证据类型、等级与局限
- 证据类型:临床实践指南;方法:检索MedLine和Cochrane Library(法语和英语)并复习1980至2019年主要国外指南;证据等级采用LE2、LE3及专业共识,推荐强度采用grade B。
- 局限:原文未报告局限性。
对床旁实践的改变
- 足月臀位产妇应被告知尝试ECV以降低臀位分娩率和剖宫产率(专业共识)。
- ECV尝试需具备可立即急诊剖宫产的手术室条件(专业共识)。
- 足月ECV推荐使用胃肠外宫缩抑制药(β受体激动剂或阿托西班)以提高成功率(grade B)。
- ECV操作前及操作后30分钟内行胎心监护(专业共识),不推荐ECV后延迟胎心监护(专业共识)。
- 不推荐ECV后常规Kleihauer试验(专业共识),Rh-1阴性妇女应系统预防(专业共识)。
- 足月臀位不推荐针灸、艾灸和体位方法(Grade B)。
指南或共识出处
- CNGOF临床实践指南:臀位——外倒转术及其他转胎干预(Gynecol Obstet Fertil Senol)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To provide guidelines regarding efficiency and safety of external cephalic version (ECV) attempt and alternatives methods to turn breech babies to cephalic presentation.
METHODS: MedLine and Cochrane Library databases search in French and English and review of the main foreign guidelines between 1980 and 2019.
RESULTS: ECV is associated with a decreasing rate of breech presentation at birth (LE2), and potentially with a lower rate of cesarean section (LE3) without an increase of severe maternal (LE3) and perinatal morbidity (LE3). It is therefore recommended to inform women with a breech presentation at term that ECV should be attempt (Professional consensus). ECV attempt should be performed with immediate access to an operating room for emergency cesarean (Professional consensus). The ECV attempt before 37 weeks, compared to ECV attempt after 37 weeks, increases the rate of cephalic presentation at birth (LE2) but with a small increase risk of moderate prematurity (LE2). ECV attempt should be performed from 36SA (Professional consensus). The main factors associated with successful ECV attempt are multiparity (LE3) and no maternal obesity (LE3). Parenteral tocolysis (β mimetic or atosiban), for ECV attempt at term is associated with a higher success rate (LE2), higher rate of achieved cephalic presentation in labor (LE2) and a lower cesarean section rate (LE2). It is recommended to use parenteral tocolysis for ECV attempt at term in order to increase its success rate (grade B). The ECV attempt is associated with an increase in transient FHR abnormalities (LE3), it is therefore recommended that cardiotocography should be performed prior and during 30minutes after the procedure (Professional consensus). There is no argument for recommending the practice of delayed cardiotocography after ECV attempt (Professional consensus). The risk of significant positivity (>30mL) of the Kleihauer test after ECV attempt is low (<0.1%) (LE3), it is not recommended to systematically perform a Kleihauer test after ECV attempt (professional consensus). In case of RH-1 negative women, it is recommended to ensure systematic RH-1 prophylaxis (Professional consensus). In case of breech presentation at term, acupuncture, moxibustion and postural methods are not effective in reducing breech presentation at birth (LE2), and are therefore not recommended (Grade B).
CONCLUSION: According to the clear benefits and the low risks of ECV attempt, all women with a breech presentation at term should be informed that ECV should be attempted to decrease breech presentation at birth and cesarean section.
参考来源
- Ducarme G. [Breech Presentation: CNGOF Guidelines for Clinical Practice - External Cephalic Version and other Interventions to turn Breech Babies to Cephalic Presentation]. Gynecol Obstet Fertil Senol. 2019. PMID: 31678503. doi:10.1016/j.gofs.2019.10.024
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。